会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 64. 发明公开
    • SELECTION AND USE OF ANTIVIRAL PEPTIDES
    • VERWENDUNG ANTIVIRALER PEPTIDE
    • EP0724650A4
    • 1998-12-02
    • EP94923428
    • 1994-07-08
    • UNIV PITTSBURGH
    • DELUCA NEAL A
    • C12N15/09C12P21/02C12Q1/68C12Q1/70C12R1/19G01N33/569
    • G01N33/56994
    • The present invention relates to the screening and selection of potential antiviral compounds or peptides. Potential antiviral compounds or peptides are chosen by their ability to interact and interfere with an essential function of a wild type viral protein subsequent to host infection. Potential antiviral compounds or peptides or pools thereof are screened in an in vitro reconstitution assay comprising a wild type viral protein, host cellular trans-acting factors and an appropriate DNA promoter fragment. A potential antiviral agent possesses the ability to form a unique protein:protein or DNA:protein complex in comparison to interactions involving the wild type viral protein in the absence of the antiviral agent.
    • 本发明涉及潜在的抗病毒化合物或肽的筛选和选择。 潜在的抗病毒化合物或肽通过其在宿主感染后相互作用并干扰野生型病毒蛋白的基本功能的能力来选择。 在包含野生型病毒蛋白,宿主细胞反式作用因子和合适的DNA启动子片段的体外重建测定中筛选潜在的抗病毒化合物或其肽或其库。 与不存在抗病毒剂的野生型病毒蛋白相互作用相比,潜在的抗病毒剂具有形成独特蛋白质的能力:蛋白质或DNA:蛋白质复合物。